Major label update to patient and HCP sites for Tarceva
Tarceva treats people with lung and pancreatic cancer, by helping to stop the growth of cancer cells. The original patient and HCP websites contained a massive amount of information, requiring ongoing maintenance updates. Due to a mandated FDA label update and upcoming sales meeting, Genentech tasked Havas with large site refreshes, with very tight holiday deadlines. This became a full-time production, with updates to a 360-page development deck. The label update took loads of hours, late nights and plenty of teamwork to complete.
Agency: Havas, San Francisco
Client: Genentech
Brand/Product: Tarceva
Websites: Tarceva Patient, Tarceva HCP